Skip to main content

MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about compliances-certificate

02 Apr 2024 Evaluate
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Glaxosmithkline Pharmaceuticals has enclosed a copy of the Certificate received from Kfin Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..